TenNor Therapeutics (Suzhou) Limited

Research TenNor Therapeutics (Suzhou) Limited (6872.HK) on Bullrun: market cap HKD 5.32B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6872.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Market capHKD 5.32B
Financial periodFY2025
RevenueCNY 0
Net income-CNY 153.24M
Free cash flow-CNY 87.65M

Valuation Snapshot

latest market cap is HKD 5.32B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 0	-CNY 153.24M	-CNY 87.65M	n/a	-2.96	CNY 183.77M	CNY 28.65M	CNY 153.86M
FY2024	CNY 0	-CNY 145.93M	-CNY 48.80M	n/a	-2.82	CNY 97.82M	CNY 53.02M	-CNY 898.05M
FY2023	CNY 0	-CNY 191.84M	-CNY 98.63M	n/a	-3.71	CNY 58.11M	CNY 59.42M	-CNY 758.91M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 5.32B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About TenNor Therapeutics (Suzhou) Limited

TenNor Therapeutics (Suzhou) Limited engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism. The company's offerings include drug production and medical research and experimental development, with a pipeline of products such as Rifasutenizole (TNP-2198) for treatment of Helicobacter pylori infection;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)

Frequently asked questions

What is TenNor Therapeutics (Suzhou) Limited's market cap?

TenNor Therapeutics (Suzhou) Limited's market capitalization is HKD 5.32B.

What does TenNor Therapeutics (Suzhou) Limited do?

TenNor Therapeutics (Suzhou) Limited engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism.